ILUMIEN III: OPTIMIZE PCI



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:11/24/2017
Start Date:May 2015
End Date:May 25, 2017

Use our guide to learn which trials are right for you!

ILUMIEN III: OPTIMIZE PCI OPtical Coherence Tomography (OCT) Compared to Intravascular Ultrasound (IVUS) and Angiography to Guide Coronary Stent Implantation: a Multicenter RandomIZEd Trial in Percutaneous Coronary Intervention (PCI)

To demonstrate the safety and efficacy of an OCT guided strategy for stent implantation.

This is a prospective, post market, international, multi-center, randomized trial.

Patients undergoing coronary angiography with possibility of PCI will be consented to
participate in the study. Patients who provide informed consent and who meet all eligibility
criteria will be randomized 1:1:1 to undergo PCI with either OCT, IVUS, or Angiography
guidance.

All patients will undergo baseline and post PCI imaging with their randomized modality. In
addition, the Angiography and IVUS groups will undergo a blinded post-PCI OCT run to allow
comparison of OCT derived minimum stent area (MSA) in both groups.

After hospital discharge, all patients will have clinical follow-up at 30 days and 1 year.

General Inclusion Criteria:

1. Age ≥ 18 years.

2. Patient with an indication for PCI including:

- Angina (stable or unstable),

- Silent ischemia (a visually estimated target lesion diameter stenosis of ≥70%, a
positive non-invasive stress test, or fractional flow reserve (FFR) ≤0.80 must be
present),

- Non-ST segment elevation myocardial infarction (NSTEMI), or

- Recent ST segment elevation myocardial infarction (STEMI) (>24 hours from initial
presentation and stable).

3. Patients will undergo cardiac catheterization and possible or definite PCI with intent
to stent using any non-investigational metallic drug-eluting stent (DES)

4. Signed written informed consent

Angiographic inclusion criteria:

1. The target lesion must be located in a native coronary artery with visually estimated
reference vessel diameter of ≥2.25 mm to ≤3.50 mm.

2. Lesion length <40mm Note: Overlapping stents are allowed

General Exclusion Criteria:

1. Estimated creatinine clearance <30 ml/min using Cockcroft-Gault equation, unless the
patient is on dialysis

2. STEMI within 24 hours of initial time of presentation to the first treating hospital,
whether at a transfer facility or the study hospital.

3. PCI within 24 hours preceding the study procedure.

4. PCI of a lesion within the target vessel within 12 months prior to the study procedure

5. Planned use of bare metal stent (BMS)

6. Planned use of bioresorbable vascular scaffold (BVS)

7. Cardiogenic shock (defined as persistent hypotension (systolic blood pressure <90
mm/Hg for more than 30 minutes) or requiring pressors or hemodynamic support,
including Intra-aortic balloon pump (IABP), at time of procedure.

8. Mobitz II second degree or complete heart block

9. Malignant ventricular arrhythmias requiring treatment

10. Pulmonary edema defined as patient with shortness of breath, evidence of volume
overload on physical exam, and crepitations on physical exam (>1/3 of lungs) or
radiographic interstitial or alveolar pulmonary edema

11. Subject is intubated.

12. Known left ventricular ejection fraction (LVEF) <30%.

13. Severe valvular disease (e.g. severe mitral regurgitation or severe aortic stenosis)

14. Cerebrovascular accident ( CVA) or transient ischemic attack within the past 6 months,
or any permanent neurologic defect attributed to CVA.

15. Presence of one or more co-morbidities which reduces life expectancy to less than 12
months or may interfere with protocol study processes.

16. Known allergy to protocol-required concomitant medications including aspirin;
clopidogrel, prasugrel, and ticagrelor; heparin and bivalirudin; or iodinated contrast
that cannot be adequately pre-medicated.

17. Patient is participating in any other investigational drug or device clinical trial
that has not reached its primary endpoint.

18. Women who are pregnant or breastfeeding (women of child-bearing potential must have a
negative pregnancy test within one week before treatment).

Angiographic Exclusion Criteria:

1. The presence of any non-study lesion in the target vessel with angiographic diameter
stenosis >50%, or any additional target vessel stenosis which requires PCI either
during or within 12 months after the study procedure

Note: Patients may have non-study lesions in a non-target vessel that require PCI.
These lesions must be treated prior to randomization, with the procedure being
successful and uncomplicated. Alternatively non-study lesions in a non-target vessel
may be treated >24 hours prior to or >48 hours after the study procedure.

Successful and uncomplicated procedure is defined as <30% visually estimated residual
diameter stenosis, Thrombolysis In Myocardial Infarction (TIMI) Grade 3 flow, no
dissection ≥ National Heart, Lung and Blood Institute (NHLBI) type C, no perforation,
no prolonged chest pain or ST segment elevation or depression (>30 minutes), no
peri-procedural myocardial infarction (MI) as measured by creatine kinase-MB (CKMB)
>5x upper limits of normal (ULN) or troponin >35x ULN.

2. Left main diameter stenosis ≥30% or left main PCI planned.

3. Study target lesion in a bypass graft

4. Ostial right coronary artery (RCA) study target lesion

5. Chronic total occlusion (TIMI flow 0/1) study target lesion

6. Bifurcation study lesion with a planned dual stent strategy

7. In-stent restenosis study target lesion

8. Any study lesion characteristic resulting in the expected inability to deliver the
IVUS or OCT catheter to the lesion pre and post PCI (e.g. moderate or severe vessel
calcification or tortuosity)
We found this trial at
21
sites
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
24 Sturtevant St
Orlando, Florida 32806
?
mi
from
Orlando, FL
Click here to add this to my saved trials
4502 Medical Drive
San Antonio, Texas 78284
(210) 567-7000
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Aalst, East Flanders 9300
?
mi
from
Aalst,
Click here to add this to my saved trials
1364 Clifton Rd NE
Atlanta, Georgia 30322
(404) 712-2000
Emory University Hospital As the largest health care system in Georgia and the only health...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Austin, Texas 78756
?
mi
from
Austin, TX
Click here to add this to my saved trials
Bend, Oregon 97701
?
mi
from
Bend, OR
Click here to add this to my saved trials
Broomfield, Colorado 80021
?
mi
from
Broomfield, CO
Click here to add this to my saved trials
Gainesville, Georgia 30501
?
mi
from
Gainesville, GA
Click here to add this to my saved trials
Greenville, North Carolina 27834
?
mi
from
Greenville, NC
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Kansas City, Kansas
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
La Jolla, California 92037
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Manhasset, New York 11030
?
mi
from
Manhasset, NY
Click here to add this to my saved trials
2900 W Oklahoma Ave
Milwaukee, Wisconsin 53215
414-649-6000
Aurora St. Luke's Medical Center At Aurora St. Luke's Medical Center, you'll find remarkable treatment...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Oklahoma City, Oklahoma
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Roslyn, New York 11576
?
mi
from
Roslyn, NY
Click here to add this to my saved trials
34800 Bob Wilson Drive
San Diego, California 92103
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Scottsdale, Arizona 85258
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Worcester, Massachusetts 01655
?
mi
from
Worcester, MA
Click here to add this to my saved trials